Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines

Prevalence and alternative therapy methods for bee and wasp allergy in Van

(2010) K. Onbaşı et al.   ALLERGY

Allergy to bumblebee venom. II IgE cross-reactivity between bumblebee and honeybee venom

(2010) S. O. Stapel et al.   ALLERGY

Safety of angiotensin-converting enzyme inhibitors while receiving venom immunotherapy

(2010) Kevin M. White et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

Immunotherapy improves health-related quality of life of adult patients with dermal reactions following yellow jacket stings

(2009) J. N.G. Oude Elberink et al.   CLINICAL AND EXPERIMENTAL ALLERGY

Assessing anaphylactic risk? Consider mast cell clonality

(2009) Dean D. Metcalfe et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels

(2009) Patrizia Bonadonna et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

ALLERGY Net: High omalizumab dose controls recurrent reactions to venom immunotherapy in indolent systemic mastocytosis

(2008) K. Kontou-Fili   ALLERGY

Kreuzreaktivität auf Bienen- und Wespengift

(2008) W. Hemmer   HAUTARZT

Fatal Anaphylactic Sting Reaction in a Patient with Mastocytosis

(2008) N. Wagner et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis

(2008) David González de Olano et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and Hymenoptera allergy

(2008) Patrizia Bonadonna et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Clinical and immunologic effects of H1 antihistamine preventive medication during honeybee venom immunotherapy

(2008) Ulrich R. Müller et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY